Generated by Llama 3.3-70B| Nant Capital | |
|---|---|
![]() | |
| Name | Nant Capital |
| Type | Private |
| Industry | Investment |
| Founder | Patrick Soon-Shiong |
| Headquarters | Los Angeles, California |
| Key people | Patrick Soon-Shiong |
Nant Capital is a private investment firm founded by Patrick Soon-Shiong, a billionaire and philanthropist known for his work in biotechnology and healthcare. As the founder of Abraxis BioScience and American Pharmaceutical Partners, Patrick Soon-Shiong has been involved in various biotechnology and pharmaceutical companies, including Allergan and Pfizer. Nant Capital is part of the NantWorks ecosystem, which includes companies such as NantHealth and NantOmics, and has investments in various industries, including technology, healthcare, and real estate, with partners like Google and Intel.
Nant Capital Nant Capital is a private investment firm that focuses on investing in innovative companies and technologies, particularly in the areas of biotechnology, healthcare, and information technology. The firm is led by Patrick Soon-Shiong, who has a strong background in medicine and biotechnology, having developed Abraxane, a cancer treatment, and founded American Pharmaceutical Partners, which was later acquired by Fresenius Kabi. Nant Capital has invested in companies such as NantHealth, which provides healthcare information technology solutions, and NantOmics, which offers genomic analysis and precision medicine services, with collaborations with Stanford University and University of California, Los Angeles.
The history of Nant Capital is closely tied to the career of its founder, Patrick Soon-Shiong, who has been involved in various biotechnology and pharmaceutical companies, including Allergan and Pfizer. Patrick Soon-Shiong founded Abraxis BioScience in 2001, which was later acquired by Celgene for USD2.9 billion, and American Pharmaceutical Partners, which was acquired by Fresenius Kabi for USD4.6 billion. Nant Capital was established as part of the NantWorks ecosystem, which includes companies such as NantHealth and NantOmics, and has partnerships with Google, Intel, and Illumina.
Nant Capital has invested in a diverse range of companies and industries, including biotechnology, healthcare, information technology, and real estate. The firm's portfolio includes companies such as NantHealth, which provides healthcare information technology solutions, and NantOmics, which offers genomic analysis and precision medicine services, with collaborations with Harvard University and Massachusetts Institute of Technology. Nant Capital has also invested in companies such as Alibaba Group, Facebook, and Amazon, and has partnerships with Microsoft, Cisco Systems, and Oracle Corporation.
The leadership and management of Nant Capital are led by Patrick Soon-Shiong, who serves as the firm's chairman and chief executive officer. Patrick Soon-Shiong has a strong background in medicine and biotechnology, having developed Abraxane, a cancer treatment, and founded American Pharmaceutical Partners, which was later acquired by Fresenius Kabi. The firm's management team includes experienced professionals from the biotechnology, healthcare, and finance industries, with backgrounds from companies like Goldman Sachs, Morgan Stanley, and J.P. Morgan.
The financial performance and impact of Nant Capital are significant, with the firm having invested in various companies and industries, including biotechnology, healthcare, and information technology. The firm's investments have generated significant returns, with NantHealth and NantOmics experiencing rapid growth and expansion, and partnerships with University of California, San Francisco and Duke University. Nant Capital has also had a positive impact on the economy, with the firm's investments creating jobs and stimulating economic growth, particularly in the Los Angeles area, with collaborations with Los Angeles County and City of Los Angeles. Nant Capital has also been involved in various philanthropic efforts, including the Patrick Soon-Shiong Foundation, which supports education and healthcare initiatives, with partnerships with Bill and Melinda Gates Foundation and Chan Zuckerberg Initiative.